Novavax secures a non-exclusive licensing deal with Pfizer, validating Matrix-M's platform value and shifting NVAX toward a technology provider model. NVAX receives $30M upfront, a potential $500M in ...

Novavax has agreed to a deal to let Pfizer use Matrix-M adjuvant in its products for an upfront payment of $30 million and up to another $500 million in milestone payments. The biotech company said ...

Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine programs. The tech, called Matrix-M, is designed to trigger an immune ...

Cybercriminals have a new, user-friendly tool for turning your browser alerts into a vector for phishing attacks. "Matrix Push" is slick, it's pretty, and it's about as easy to use as any commercial ...

To better understand which social media platforms Americans use, Pew Research Center surveyed 5,022 U.S. adults from Feb. 5 to June 18, 2025. SSRS conducted this National Public Opinion Reference ...

TL;DR: ASUS has officially introduced the Level Sense feature to prevent GPU sag by using sensors to monitor whether the board is sagging in real-time, and warn the owner if this is happening. This ...

With technology continuing to change the way the world travels, there are certain aspects of the airline game that remain very much in the realm of the so-called "old school." Airplanes themselves, ...

Gradient Ventures has spun out of Google to better position itself to win deals in the fast-moving early-stage AI market, according to people familiar with the situation. Gradient Ventures is now ...

(RTTNews) - Novavax, Inc. (NVAX) announced Tuesday progress on its collaboration and license agreement (CLA) with Sanofi SA (SNY) regarding Novavax's Matrix-M adjuvant. The companies have amended ...

Kara Alaimo is an associate professor of communication at Fairleigh Dickinson University. Her book “Over the Influence: Why Social Media Is Toxic for Women and Girls — And How We Can Take It Back” was ...

Liam Gaughan is a film and TV writer at Collider. He has been writing film reviews and news coverage for ten years. Between relentlessly adding new titles to his watchlist and attending as many ...